Local recurrence after laparoscopic resection of T3 rectal cancer without preoperative chemoradiation and a risk group analysis: an Asian collaborative study
- PMID: 17957433
- DOI: 10.1007/s11605-007-0386-6
Local recurrence after laparoscopic resection of T3 rectal cancer without preoperative chemoradiation and a risk group analysis: an Asian collaborative study
Abstract
Risk factors for local recurrence and indication for preoperative radiation therapy have not been well evaluated for patients undergoing laparoscopic rectal cancer operation. From 1998 to 2004, 497 T3 rectal cancer patients with tumor located within 12 cm from the anal verge who had undergone laparoscopic surgery without preoperative radiation therapy by eight experienced laparoscopic surgeons in four Asian countries were reviewed retrospectively for the incidence of local recurrence and related factors. The median follow-up was 29.0 months (range, 6.0 to 92.3), and 31 cases of local recurrence were observed during the follow-up period (6 anastomosis site, 6 perineum, 17 pelvic wall, and 2 unclassified). The estimated local recurrence rates at 24 and 60 months were 5.42 and 9.41%, respectively. Patient's gender, tumor location, lymph node metastasis, and tumor perforation were independent factors for local recurrence by multivariate analysis. The local recurrence rate was comparable to previous studies using conventional open surgery with preoperative chemoradiation, except for a subgroup of male patients with the tumor located within 7 cm from the anal verge. The indication for preoperative radiation therapy would be different from those who will undergo conventional open surgery, and further evaluation of the benefits of preoperative radiation therapy is required for those with low risk tumor.
Similar articles
-
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1098-105. doi: 10.1016/j.ijrobp.2004.04.062. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519780
-
Evolving role of neoadjuvant therapy in rectal cancer.Curr Treat Options Oncol. 2013 Sep;14(3):350-64. doi: 10.1007/s11864-013-0242-8. Curr Treat Options Oncol. 2013. PMID: 23828092
-
Video. Advantages of the laparoscopic approach for intersphincteric resection.Surg Endosc. 2011 May;25(5):1661-3. doi: 10.1007/s00464-010-1451-x. Epub 2010 Dec 4. Surg Endosc. 2011. PMID: 21132330
-
Long-term results of laparoscopic versus open resections for rectal cancer for 124 unselected patients.Surg Endosc. 2003 Oct;17(10):1530-5. doi: 10.1007/s00464-002-8874-y. Epub 2003 Jul 21. Surg Endosc. 2003. PMID: 12874687 Clinical Trial.
-
Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes.Surg Endosc. 2004 Feb;18(2):281-9. doi: 10.1007/s00464-002-8877-8. Epub 2003 Dec 29. Surg Endosc. 2004. PMID: 14691716 Review.
Cited by
-
Laparoscopic surgery for rectal cancer.Perm J. 2009 Winter;13(1):47-52. doi: 10.7812/TPP/08-058. Perm J. 2009. PMID: 21373245 Free PMC article.
-
Clinical study on risk factors related to postoperative recurrence or metastasis of rectal cancer: a retrospective cohort study.J Gastrointest Oncol. 2022 Dec;13(6):2973-2988. doi: 10.21037/jgo-22-942. J Gastrointest Oncol. 2022. PMID: 36636070 Free PMC article.
-
A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for rectal cancer.J Gastrointest Surg. 2011 Aug;15(8):1375-85. doi: 10.1007/s11605-011-1547-1. Epub 2011 May 10. J Gastrointest Surg. 2011. PMID: 21557014
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources